RECRUITING

Minds Navigating the Diagnosis of Mild Cognitive Impairment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.

Official Title

Minds Navigating the Diagnosis of Mild Cognitive Impairment (MiND-MCI)

Quick Facts

Study Start:2023-10-01
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05690243

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Veteran
  2. * age 60 or older
  3. * diagnosis of MCI, diagnosed at least a month or longer prior to screening
  4. * diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)
  5. * self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?")
  6. * self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?")
  7. * English speaking, and (h) ability to provide written informed consent
  1. * diagnosis of dementia or a neurodegenerative disorder
  2. * diagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder)
  3. * acutely suicidal or homicidal
  4. * actively psychotic
  5. * active substance use disorder
  6. * limited life expectancy due to a terminal medical condition
  7. * receiving ongoing chemotherapy or radiation treatment at time of screening
  8. * residing in an assisted living or residential care facility
  9. * currently participating in another psychotherapy, health promotion intervention, or cognitive training program, and
  10. * any significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.

Contacts and Locations

Study Contact

Patricia Pilkinton, MD
CONTACT
205-554-20944
patricia.pilkinton@va.gov
Lindsay Jacobs, PhD
CONTACT
205-554-2337
jacob008@ua.edu

Principal Investigator

Patricia Pilkinton, MD
PRINCIPAL_INVESTIGATOR
Tuscaloosa Veterans Affairs Medical Center
Lindsay Jacobs, PhD
PRINCIPAL_INVESTIGATOR
Tuscaloosa Veterans Affairs Medical Center

Study Locations (Sites)

Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, 35404
United States
Salem VA Medical Center
Salem, Virginia, 24153
United States

Collaborators and Investigators

Sponsor: Tuscaloosa Research & Education Advancement Corporation

  • Patricia Pilkinton, MD, PRINCIPAL_INVESTIGATOR, Tuscaloosa Veterans Affairs Medical Center
  • Lindsay Jacobs, PhD, PRINCIPAL_INVESTIGATOR, Tuscaloosa Veterans Affairs Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-01
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2023-10-01
Study Completion Date2025-09-30

Terms related to this study

Keywords Provided by Researchers

  • therapy
  • video telehealth
  • veteran

Additional Relevant MeSH Terms

  • Cognitive Dysfunction
  • Mild Cognitive Impairment